Media

KDA develops innovative solutions for global markets that drive health system transformation. To contact us, write to info@groupekda.ca

KDA Group acquires Covapharm

2022-12-21 00:00:54

Thetford Mines, Quebec – December 21, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that it has acquired Covapharm Inc. (“Covapharm”) pursuant to a share purchase agreement (the “Share Purchase Agreement”) dated December 16, 2022, for a consideration of $200,000.00 payable in monthly instalments of $10,000.00 over a period of twenty (20) months from the closing date and a maximum of 1,825,000 Class A shares in the capital stock of the Corporation (the “KDA Shares”).

Learn more

KDA GROUP provides clarification and update on the termination of its former chief financial officer

2022-11-03 00:00:00

Thetford Mines, Quebec – November 3, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) provides clarification and an update on the termination of employment of its former Chief Financial Officer, Mr. Pierre Monet and announces claims against him.

Learn more

KDA GROUP ANNOUNCES THE APPOINTMENT OF Luc Olivier as chief financial officer,18 OCTOBER 2022

2022-10-18 00:00:00

Thetford Mines, Quebec – October 18, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the appointment of Mr. Luc Olivier as Chief Financial Officer of the Corporation effective yesterday, October 17, 2022.

Learn more

KDA GROUP ANNOUNCES THE APPOINTMENT OF MICHAEL W. KINLEY AS INTERIM CHIEF FINANCIAL OFFICER

2022-07-29 00:00:00

Thetford Mines, Quebec – July 29, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces the departure of Mr. Pierre Monet as Chief Financial Officer of the Corporation effective immediately.

Learn more

kda group grants stock options

2022-05-06 00:00:00

Thetford Mines, Quebec – May 6, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that, pursuant to its stock option plan, it has granted incentive stock options to directors, officers, employees and consultants of the Corporation to purchase up to an aggregate of 5,025,000 Class A shares (the “Common shares”).

Learn more
1 2